Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic AcidViscosupplementationReport Summar...
TABLE OF CONTENTSTABLE OF CONTENTS.ILIST OF FIGURESVIIILIST OF CHARTS XVIIIEXECUTIVE SUMMARY. 11.1 TOTAL ASIA-PACIFIC ORTH...
3.8.1 Herfindahl Index . 643.9 MERGERS AND ACQUISITIONS 66COUNTRY PROFILES 674.1 INTRODUCTION . 674.1.1 Population. 674.1....
6.3.2.12 Synthetic Craniomaxillofacial Market.1506.3.2.13 Total DBM Market.1536.3.2.14 DBM Spine Market 156Table of Conten...
6.5.2.9 Synthetic Cervical Spine Market .2716.5.2.10 Synthetic Thoracolumbar Spine Market 2746.5.2.11 Synthetic Trauma & R...
8.4.2.2 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market 3338.4.3 Market Drivers and Limiters 3368.4.3.1 M...
(JP¥M) 38Figure 3-8: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017(US$M) . 43List of FiguresFigure 3-9: Or...
(US$M) . 113Figure 6-16: Bone Graft Substitute Market by Segment, China, 2007 – 2017(CN¥M). 113Figure 6-17: Total Allograf...
Figure 6-54: Leading Competitors, Bone Graft Substitute Market, China, 2010 174Figure 6-55: Bone Graft Substitute Market b...
Figure 6-85: DBM Cervical Spine Market, South Korea, 2007 – 2017 (US$) . 224Figure 6-86: DBM Cervical Spine Market, South ...
Figure 6-116: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017(AU$) . 275Figure 6-117: Synthetic Trauma & Reco...
Market, China, 2010 323Figure 8-13: Total Hyaluronic Acid Viscosupplementation Market, South Korea,2007 – 2017 (US$M) . 32...
2007 – 2017 (US$). 356Figure 11-3: Hyaluronic Acid Viscosupplementation Market, Taiwan,2007 – 2017 (TW$) 356APPENDIX 3: EM...
Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication,Asia-Pacific, 2017 . 75Chart 5-3: Total Orthopedic Bo...
(US$M) . 178Chart 6-31: Bone Graft Substitute Market by Segment, South Korea, 2010 179Chart 6-32: Bone Graft Substitute Ma...
Chart 6-61: Total Synthetic Market, Australia, 2007 – 2017 (US$M). 267Chart 6-62: Synthetic Total Spine Market, Australia,...
APPENDIX 2: TAIWANESE HYALURONIC ACIDVISCOSUPPLEMENTATION MARKET . 355Chart 11-1: Hyaluronic Acid Viscosupplementation Mar...
Upcoming SlideShare
Loading in …5
×

ReportsnReports – Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation

559
-1

Published on

The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market.

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
559
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

ReportsnReports – Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation

  1. 1. Asia Pacific Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic AcidViscosupplementationReport SummaryThe Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by2017. The hyaluronic acid viscosupplementation segment is expected to constitute themajority of the Asia-Pacific orthopedic biomaterials market.Buy Now: Asia Pacific Markets for Orthopedic BiomaterialsBrowse All: Latest Market Research ReportsThe Asia-Pacific orthopedic biomaterials report covers the following countries:JapanSouth KoreaAustraliaChinaThe segments covered in this report include:autologous bone grafts,bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices andsynthetics),hyaluronic acid (HA) viscosupplementation,bone morphogenetic protein (BMP) growth factor therapyautologous chondrocyte implantation (ACI)The market is approaching maturity, but is expected to continue to grow as a result of theaging Asia-Pacific population. BMP growth factor therapy was the fastest growing segmentin 2010, increasing almost 7% over the previous year.This report provides a comprehensive and detailed analysis of market revenues by devicetype, market forecasts through 2017, unit sales, average selling prices, market drivers andlimiters and a detailed competitive analysis, including manufacturer market shares andproduct portfolios.Latest Market Research Reports:Latin American Markets for Spinal Implants and VCF 2011U.S. Market for Women’s Health Devices 2011Brazilian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,Extraoral X-Ray Systems and CBCT Scanners)Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,Extraoral X-Ray Systems and CBCT Scanners)Indian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,Extraoral X-Ray Systems and CBCT Scanners)Chinese Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems,Extraoral X-Ray Systems and CBCT Scanners)U.S. Hyaluronic Acid Viscosupplementation Physician Survey 2011International Hyaluronic Acid Viscosupplementation Physician Survey 2011Production, Market and Benchmarking of Xanthan Gum in China
  2. 2. TABLE OF CONTENTSTABLE OF CONTENTS.ILIST OF FIGURESVIIILIST OF CHARTS XVIIIEXECUTIVE SUMMARY. 11.1 TOTAL ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET. 11.2 HERFINDAHL INDEX COUNTRY PROFILES 21.3 GROWTH TRENDS BY MARKET SEGMENT 31.4 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS 41.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET . 51.6 BONE MORPHOGENETIC PROTEIN MARKET . 61.7 COMPETITIVE ANALYSIS 7RESEARCH METHODOLOGY. 82.1 RESEARCH SCOPE . 82.2 IDATA’S 9-STEP METHODOLOGY . 82.2.1 Step 1: Project Initiation & Team Selection 92.2.2 Step 2: Prepare Data Systems and Perform Secondary Research. 102.2.3 Step 3: Preparation for Interviews & Questionnaire Design 112.2.4 Step 4: Performing Primary Research. 122.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 142.2.6 Step 6: Market Forecast and Analysis . 142.2.7 Step 7: Identify Strategic Opportunities 162.2.8 Step 8: Final Review and Market Release . 172.2.9 Step 9: Customer Feedback and Market Monitoring. 18ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET 193.1 INTRODUCTION . 193.1.1 Growth Factors. 20Table of Contents3.1.2 Bone Graft Substitutes 203.1.3 Hyaluronic Acid Viscosupplementation 203.2 CURRENCY EXCHANGE RATES . 213.3 MARKET OVERVIEW. 223.4 MARKET BY SEGMENT 243.5 TREND ANALYSIS BY SEGMENT . 293.6 MARKET BY COUNTRY . 323.6.1 Total Market . 323.6.2 Japan. 373.6.3 China. 423.6.4 South Korea 473.6.5 Australia . 523.7 MARKET DRIVERS AND LIMITERS 573.7.1 Market Drivers 573.7.2 Market Limiters. 583.8 COMPETITIVE ANALYSIS 59
  3. 3. 3.8.1 Herfindahl Index . 643.9 MERGERS AND ACQUISITIONS 66COUNTRY PROFILES 674.1 INTRODUCTION . 674.1.1 Population. 674.1.2 GDP per Capita 674.1.3 Price Index 674.2 JAPAN 684.3 CHINA . 694.4 SOUTH KOREA 704.5 AUSTRALIA . 71PROCEDURE NUMBERS. 725.1 OVERVIEW 725.1.1 Total Orthopedic Bone Graft Substitute Procedures by Indication 725.1.2 Total Orthopedic Bone Graft Substitute Procedures by Segment. 765.1.3 Total Orthopedic Bone Graft Substitute Procedures by Country . 80Table of ContentsBONE GRAFT SUBSTITUTE MARKET 846.1 INTRODUCTION . 846.1.1 Volumes Represented per Procedure 876.2 JAPAN 886.2.1 Market Analysis and Forecast 886.2.1.1 Volumes Represented per Procedure.886.2.1.2 Total Synthetic Market.896.2.1.3 Synthetic Spine Market 926.2.1.4 Synthetic Cervical Spine Market .956.2.1.5 Synthetic Thoracolumbar Spine Market 986.2.1.6 Synthetic Trauma and Reconstruction Market 1016.2.1.7 Synthetic Craniomaxillofacial Market.1046.2.2 Market Drivers and Limiters 1076.2.2.1 Market Drivers.1076.2.2.2 Market Limiters .1076.2.3 Competitive Analysis. 1096.3 CHINA . 1126.3.1 Overview. 1126.3.2 Market Analysis and Forecast 1176.3.2.1 Total Allograft Market.1176.3.2.2 Allograft Spine Market 1206.3.2.3 Allograft Cervical Spine Market1236.3.2.4 Allograft Thoracolumbar Spine Market 1266.3.2.5 Allograft Trauma & Reconstruction Market .1296.3.2.6 Allograft Craniomaxillofacial Market .1326.3.2.7 Total Synthetic Market.1356.3.2.8 Synthetic Spine Market 1386.3.2.9 Synthetic Cervical Spine Market .1416.3.2.10 Synthetic Thoracolumbar Spine Market 1446.3.2.11 Synthetic Trauma & Reconstruction Market .147
  4. 4. 6.3.2.12 Synthetic Craniomaxillofacial Market.1506.3.2.13 Total DBM Market.1536.3.2.14 DBM Spine Market 156Table of Contents6.3.2.15 DBM Cervical Spine Market .1596.3.2.16 DBM Thoracolumbar Spine Market 1626.3.2.17 DBM Trauma & Reconstruction Market .1656.3.2.18 DBM Craniomaxillofacial Market.1686.3.3 Market Drivers and Limiters 1716.3.3.1 Market Drivers.1716.3.3.2 Market Limiters .1716.3.4 Competitive Analysis. 1736.4 SOUTH KOREA 1766.4.1 Overview. 1766.4.2 Market Analysis and Forecast 1816.4.2.1 Total Allograft Market.1816.4.2.2 Allograft Spine Market 1846.4.2.3 Allograft Cervical Spine Market1876.4.2.4 Allograft Thoracolumbar Spine Market 1906.4.2.5 Allograft Trauma & Reconstruction Market .1936.4.2.6 Allograft Craniomaxillofacial Market .1966.4.2.7 Total Synthetic Market.1996.4.2.8 Synthetic Spine Market 2026.4.2.9 Synthetic Cervical Spine Market .2056.4.2.10 Synthetic Thoracolumbar Spine Market 2086.4.2.11 Synthetic Trauma & Reconstruction Market .2116.4.2.12 Synthetic Craniomaxillofacial Market.2146.4.2.13 Total Demineralized Bone Matrix Market.2176.4.2.14 DBM Spine Market 2206.4.2.15 DBM Cervical Spine Market .2236.4.2.16 DBM Thoracolumbar Spine Market 2266.4.2.17 DBM Trauma & Reconstruction Market .2296.4.2.18 DBM Craniomaxillofacial Market.2326.4.3 Market Drivers and Limiters 2356.4.3.1 Market Drivers.2356.4.3.2 Market Limiters .2356.4.4 Competitive Analysis. 2376.5 AUSTRALIA . 241Table of Contents6.5.1 Overview. 2416.5.2 Market Analysis and Forecast 2466.5.2.1 Total Allograft Market.2466.5.2.2 Allograft Spine Market 2506.5.2.3 Allograft Cervical Spine Market2536.5.2.4 Allograft Thoracolumbar Spine Market 2566.5.2.5 Allograft Trauma & Reconstruction Market .2596.5.2.6 Allograft Craniomaxillofacial Market .2626.5.2.7 Total Synthetic Market.2656.5.2.8 Synthetic Spine Market 268
  5. 5. 6.5.2.9 Synthetic Cervical Spine Market .2716.5.2.10 Synthetic Thoracolumbar Spine Market 2746.5.2.11 Synthetic Trauma & Reconstruction Market .2776.5.2.12 Synthetic Craniomaxillofacial Market.2806.5.3 Market Drivers and Limiters 2836.5.3.1 Market Drivers.2836.5.3.2 Market Limiters .2846.5.4 Competitive Analysis. 285BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPYMARKET 2897.1 INTRODUCTION . 2897.1.1 Overview. 2897.1.2 Potential Complications . 2907.2 AUSTRALIA . 2917.2.1 Market Analysis and Forecast 2917.2.1.1 Total BMP Market .2917.2.2 Market Drivers and Limiters 2947.2.2.1 Market Drivers.2947.2.2.2 Market Limiters .2957.2.3 Competitive Analysis. 297HYALURONIC ACID VISCOSUPPLEMENTATION MARKET . 2998.1 INTRODUCTION . 299Table of Contents8.1.1.1 Single-Injection Products 3008.1.1.2 Three-Injection Cycle Products.3008.1.1.3 Five-Injection Cycle Products .3008.2 JAPAN 3018.2.1 Market Analysis and Forecast 3018.2.1.1 Total Hyaluronic Acid Viscosupplementation Market.3018.2.2 Market Drivers and Limiters 3048.2.2.1 Market Drivers.3048.2.2.2 Market Limiters .3058.2.3 Competitive Analysis. 3068.3 CHINA . 3098.3.1 Market Analysis and Forecast 3098.3.1.1 Total Hyaluronic Acid Viscosupplementation Market.3098.3.2 Market Analysis and Forecast 3148.3.2.1 Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market 3148.3.2.2 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market 3178.3.3 Market Drivers and Limiters 3208.3.3.1 Market Drivers.3208.3.3.2 Market Limiters .3218.3.4 Competitive Analysis. 3228.4 SOUTH KOREA 3258.4.1 Overview. 3258.4.2 Market Analysis and Forecast 3308.4.2.1 Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market 330
  6. 6. 8.4.2.2 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market 3338.4.3 Market Drivers and Limiters 3368.4.3.1 Market Drivers.3368.4.3.2 Market Limiters .3378.4.4 Competitive Analysis. 3388.5 AUSTRALIA . 3418.5.1 Market Analysis and Forecast 3418.5.2 Market Drivers and Limiters 3448.5.2.1 Market Drivers.3448.5.2.2 Market Limiters .344Table of Contents8.5.3 Competitive Analysis. 345ABBREVIATIONS 347APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BYWEIGHT. 348APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATIONMARKET 355APPENDIX 3: EMERGING MARKETS . 35812.1 BONE MORPHOGENETIC PROTEIN MARKET . 35812.2 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET 358List of FiguresLIST OF FIGURESEXECUTIVE SUMMARY 1Figure 1-1: Total Orthopedic Biomaterials Market, Asia-Pacific, 2010 (US$M). 1Figure 1-2: Herfindahl Index by Country, Asia-Pacific, 2010 . 2Figure 1-3: Growth Trends, Orthopedic Biomaterials Market, Asia-Pacific, 2007– 2017 . 3Figure 1-4: Procedure Numbers, Bone Graft Substitute Market, Asia-Pacific,2007 – 2017. 4Figure 1-5: Growth Rates, Hyaluronic Acid Viscosupplementation Market,Asia-Pacific, 2007 – 2017 5Figure 1-6: Bone Morphogenetic Protein Market, Australia, 2007 – 2017 (US$M) . 6Figure 1-7: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,2010 7RESEARCH METHODOLOGY 8ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET . 19Figure 3-1: Exchange Rate for Currencies, 2010 . 21Figure 3-2: Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017 22Figure 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific,2007 – 2017 (US$M) . 25Figure 3-4: Growth Rates by Segment, Orthopedic Biomaterials Market,Asia-Pacific, 2007 – 2017 30Figure 3-5: Orthopedic Biomaterials Market by Country, Asia-Pacific,2007 – 2017 (US$M) . 33Figure 3-6: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017(US$M) . 38Figure 3-7: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017
  7. 7. (JP¥M) 38Figure 3-8: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017(US$M) . 43List of FiguresFigure 3-9: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017(CN¥M). 43Figure 3-10: Orthopedic Biomaterials Market by Segment, South Korea,2007 – 2017 (US$M) . 48Figure 3-11: Orthopedic Biomaterials Market by Segment, South Korea,2007 – 2017 (KR₩M) 48Figure 3-12: Orthopedic Biomaterials Market by Segment, Australia,2007 – 2017 (US$M) . 53Figure 3-13: Orthopedic Biomaterials Market by Segment, Australia,2007 – 2017 (AU$M). 53Figure 3-14: Drivers and Limiters, Orthopedic Biomaterials Market, Asia-Pacific,2010 58Figure 3-15: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,2010 (1 of 2) . 61Figure 3-16: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,2010 (2 of 2) . 62Figure 3-17: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010. 64COUNTRY PROFILES 67Figure 4-1: Country Indicators, Asia-Pacific, 2010 . 68PROCEDURE NUMBERS 72Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Asia-Pacific,2007 – 2017. 73Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment,Asia-Pacific, 2007 – 2017 77Figure 5-3: Total Orthopedic Bone Graft Substitute Procedures by Country,Asia-Pacific, 2007 – 2017 81BONE GRAFT SUBSTITUTE MARKET 84Figure 6-1: Total Synthetic Market, Japan, 2007 – 2017 (US$) 90Figure 6-2: Total Synthetic Market, Japan, 2007 – 2017 (JP¥) . 90Figure 6-3: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$) 93Figure 6-4: Synthetic Total Spine Market, Japan, 2007 – 2017 (JP¥) . 93Figure 6-5: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$) . 96Figure 6-6: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (JP¥) 96Figure 6-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (US$) 99List of FiguresFigure 6-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (JP¥) . 99Figure 6-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017(US$) 102Figure 6-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017(JP¥) . 102Figure 6-11: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$). 105Figure 6-12: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (JP¥) 105Figure 6-13: Drivers and Limiters, Bone Graft Substitute Market, Japan, 2010 . 108Figure 6-14: Leading Competitors, Bone Graft Substitute Market, Japan, 2010 . 110Figure 6-15: Bone Graft Substitute Market by Segment, China, 2007 – 2017
  8. 8. (US$M) . 113Figure 6-16: Bone Graft Substitute Market by Segment, China, 2007 – 2017(CN¥M). 113Figure 6-17: Total Allograft Market, China, 2007 – 2017 (US$) 118Figure 6-18: Total Allograft Market, China, 2007 – 2017 (CN¥) . 118Figure 6-19: Allograft Total Spine Market, China, 2007 – 2017 (US$) 121Figure 6-20: Allograft Total Spine Market, China, 2007 – 2017 (CN¥) 121Figure 6-21: Allograft Cervical Spine Market, China, 2007 – 2017 (US$) 124Figure 6-22: Allograft Cervical Spine Market, China, 2007 – 2017 (CN¥) . 124Figure 6-23: Allograft Thoracolumbar Spine Market, China, 2007 – 2017(US$) 127Figure 6-24: Allograft Thoracolumbar Spine Market, China, 2007 – 2017(CN¥) 127Figure 6-25: Allograft Trauma & Reconstruction Market, China, 2007 – 2017(US$) 130Figure 6-26: Allograft Trauma & Reconstruction Market, China, 2007 – 2017(CN¥) 130Figure 6-27: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (US$) 133Figure 6-28: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (CN¥) 133Figure 6-29: Total Synthetic Market, China, 2007 – 2017 (US$) . 136Figure 6-30: Total Synthetic Market, China, 2007 – 2017 (CN¥) . 136Figure 6-31: Synthetic Total Spine Market, China, 2007 – 2017 (US$) 139Figure 6-32: Synthetic Total Spine Market, China, 2007 – 2017 (CN¥) 139Figure 6-33: Synthetic Cervical Spine Market, China, 2007 – 2017 (US$) . 142List of FiguresFigure 6-34: Synthetic Cervical Spine Market, China, 2007 – 2017 (CN¥) . 142Figure 6-35: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017 (US$)145Figure 6-36: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017(CN¥) 145Figure 6-37: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017(US$) 148Figure 6-38: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017(CN¥) 148Figure 6-39: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (US$) 151Figure 6-40: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (CN¥) 151Figure 6-41: Total DBM Market, China, 2007 – 2017 (US$) . 154Figure 6-42: Total DBM Market, China, 2007 – 2017 (CN¥) . 154Figure 6-43: DBM Total Spine Market, China, 2007 – 2017 (US$) 157Figure 6-44: DBM Total Spine Market, China, 2007 – 2017 (CN¥) 157Figure 6-45: DBM Cervical Spine Market, China, 2007 – 2017 (US$) . 160Figure 6-46: DBM Cervical Spine Market, China, 2007 – 2017 (CN¥). 160Figure 6-47: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (US$) . 163Figure 6-48: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (CN¥). 163Figure 6-49: DBM Trauma & Reconstruction Market, China, 2007 – 2017 (US$)166Figure 6-50: DBM Trauma & Reconstruction Market, China, 2007 – 2017(CN¥) 166Figure 6-51: DBM Craniomaxillofacial Market, China, 2007 – 2017 (US$) . 169Figure 6-52: DBM Craniomaxillofacial Market, China, 2007 – 2017 (CN¥) . 169Figure 6-53: Drivers and Limiters, Bone Graft Substitute Market, China, 2010 172
  9. 9. Figure 6-54: Leading Competitors, Bone Graft Substitute Market, China, 2010 174Figure 6-55: Bone Graft Substitute Market by Segment, South Korea,2007 – 2017 (US$M) . 177Figure 6-56: Bone Graft Substitute Market by Segment, South Korea,2007 – 2017 (KR₩M) 177Figure 6-57: Total Allograft Market, South Korea, 2007 – 2017 (US$) 182Figure 6-58: Total Allograft Market, South Korea, 2007 – 2017 (KR₩) 182Figure 6-59: Allograft Total Spine Market, South Korea, 2007 – 2017 (US$) 185Figure 6-60: Allograft Total Spine Market, South Korea, 2007 – 2017 (KR₩). 185List of FiguresFigure 6-61: Allograft Cervical Spine Market, South Korea, 2007 – 2017 (US$) 188Figure 6-62: Allograft Cervical Spine Market, South Korea, 2007 – 2017(KR₩) 188Figure 6-63: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017(US$) 191Figure 6-64: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017(KR₩) 191Figure 6-65: Allograft Trauma & Reconstruction Market, South Korea,2007 – 2017 (US$). 194Figure 6-66: Allograft Trauma & Reconstruction Market, South Korea,2007 – 2017 (KR₩) . 194Figure 6-67: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017(US$) 197Figure 6-68: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017(KR₩) 197Figure 6-69: Total Synthetic Market, South Korea, 2007 – 2017 (US$) 200Figure 6-70: Total Synthetic Market, South Korea, 2007 – 2017 (KR₩) 200Figure 6-71: Synthetic Total Spine Market, South Korea, 2007 – 2017 (US$) 203Figure 6-72: Synthetic Total Spine Market, South Korea, 2007 – 2017 (KR₩) 203Figure 6-73: Synthetic Cervical Spine Market, South Korea, 2007 – 2017 (US$) 206Figure 6-74: Synthetic Cervical Spine Market, South Korea, 2007 – 2017(KR₩) 206Figure 6-75: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017(US$) 209Figure 6-76: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017(KR₩) 209Figure 6-77: Synthetic Trauma & Reconstruction Market, South Korea,2007 – 2017 (US$). 212Figure 6-78: Synthetic Trauma & Reconstruction Market, South Korea,2007 – 2017 (KR₩) . 212Figure 6-79: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017(US$) 215List of FiguresFigure 6-80: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017(KR₩) 215Figure 6-81: Total DBM Market, South Korea, 2007 – 2017 (US$) 218Figure 6-82: Total DBM Market, South Korea, 2007 – 2017 (KR₩) 218Figure 6-83: DBM Total Spine Market, South Korea, 2007 – 2017 (US$) 221Figure 6-84: DBM Total Spine Market, South Korea, 2007 – 2017 (KR₩) 221
  10. 10. Figure 6-85: DBM Cervical Spine Market, South Korea, 2007 – 2017 (US$) . 224Figure 6-86: DBM Cervical Spine Market, South Korea, 2007 – 2017 (KR₩) 224Figure 6-87: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017(US$) 227Figure 6-88: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017(KR₩) 227Figure 6-89: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017(US$) 230Figure 6-90: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017(KR₩) 230Figure 6-91: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017(US$) 233Figure 6-92: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017(KR₩) 233Figure 6-93: Drivers and Limiters, Bone Graft Substitute Market, South Korea,2010 236Figure 6-94: Leading Competitors, Bone Graft Substitute Market, South Korea,2010 239Figure 6-95: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017(US$M) . 242Figure 6-96: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017(AU$M) 242Figure 6-97: Total Allograft Market, Australia, 2007 – 2017 (US$) . 247Figure 6-98: Total Allograft Market, Australia, 2007 – 2017 (AU$) 248Figure 6-99: Allograft Total Spine Market, Australia, 2007 – 2017 (US$) . 251Figure 6-100: Allograft Total Spine Market, Australia, 2007 – 2017 (AU$) . 251Figure 6-101: Allograft Cervical Spine Market, Australia, 2007 – 2017 (US$) . 254List of FiguresFigure 6-102: Allograft Cervical Spine Market, Australia, 2007 – 2017 (AU$) 254Figure 6-103: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017(US$) 257Figure 6-104: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017(AU$) . 257Figure 6-105: Allograft Trauma & Reconstruction Market, Australia,2007 – 2017 (US$). 260Figure 6-106: Allograft Trauma & Reconstruction Market, Australia,2007 – 2017 (AU$) 260Figure 6-107: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017(US$) 263Figure 6-108: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017(AU$) 263Figure 6-109: Total Synthetic Market, Australia, 2007 – 2017 (US$). 266Figure 6-110: Total Synthetic Market, Australia, 2007 – 2017 (AU$) 266Figure 6-111: Synthetic Total Spine Market, Australia, 2007 – 2017 (US$) . 269Figure 6-112: Synthetic Total Spine Market, Australia, 2007 – 2017 (AU$). 269Figure 6-113: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (US$) 272Figure 6-114: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (AU$) 272Figure 6-115: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017(US$) 275
  11. 11. Figure 6-116: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017(AU$) . 275Figure 6-117: Synthetic Trauma & Reconstruction Market, Australia,2007 – 2017 (US$). 278Figure 6-118: Synthetic Trauma & Reconstruction Market, Australia,2007 – 2017 (AU$) 278Figure 6-119: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017(US$) 281Figure 6-120: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017(AU$) 281Figure 6-121: Drivers and Limiters, Bone Graft Substitute Market, Australia,2010 284List of FiguresFigure 6-122: Leading Competitors, Bone Graft Substitute Market, Australia,2010 287Figure 6-123: Leading Competitors, Bone Graft Substitute Market, Australia,2010 . 288BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPYMARKET 289Figure 7-1: Bone Morphogenetic Market, Australia, 2007 – 2017 (US$) 292Figure 7-2: Bone Morphogenetic Market, Australia, 2007 – 2017 (AU$) . 292Figure 7-3: Drivers and Limiters, Bone Morphogenetic Protein Market, Australia,2010 296Figure 7-4: Leading Competitors, Bone Morphogenetic Protein Market, Australia,2010 297HYALURONIC ACID VISCOSUPPLEMENTATION MARKET. 299Figure 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017(US$) 302Figure 8-2: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017(JP¥) . 302Figure 8-3: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market,Japan, 2010 . 305Figure 8-4: Leading Competitors, Hyaluronic Acid ViscosupplementationMarket, Japan, 2010. 307Figure 8-5: Total Hyaluronic Acid Viscosupplementation Market,. 310Figure 8-6: Total Hyaluronic Acid Viscosupplementation Market, China,2007 – 2017 (CN¥M) . 310Figure 8-7: Three-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, China, 2007 – 2017 (US$) . 315Figure 8-8: Three-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, China, 2007 – 2017 (CN¥). 315Figure 8-9: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market,China, 2007 – 2017 (US$) 318Figure 8-10: Five-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, China, 2007 – 2017 (CN¥). 318Figure 8-11: Drivers and Limiters, Hyaluronic Acid ViscosupplementationMarket, China, 2010 321List of FiguresFigure 8-12: Leading Competitors, Hyaluronic Acid Viscosupplementation
  12. 12. Market, China, 2010 323Figure 8-13: Total Hyaluronic Acid Viscosupplementation Market, South Korea,2007 – 2017 (US$M) . 326Figure 8-14: Total Hyaluronic Acid Viscosupplementation Market, South Korea,2007 – 2017 (KR₩M) 326Figure 8-15: Three-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, South Korea, 2007 – 2017 (US$) . 331Figure 8-16: Three-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, South Korea, 2007 – 2017 (KR₩) . 331Figure 8-17: Five-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, South Korea, 2007 – 2017 (US$) . 334Figure 8-18: Five-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, South Korea, 2007 – 2017 (KR₩) . 334Figure 8-19: Drivers and Limiters, Hyaluronic Acid ViscosupplementationMarket, South Korea, 2010 337Figure 8-20: Leading Competitors, Hyaluronic Acid ViscosupplementationMarket, South Korea, 2010 339Figure 8-21: Hyaluronic Acid Viscosupplementation Market, Australia,2007 – 2017 (US$). 342Figure 8-22: Hyaluronic Acid Viscosupplementation Market, Australia,2007 – 2017 (AU$) 342Figure 8-23: Drivers and Limiters, Hyaluronic Acid ViscosupplementationMarket, Australia, 2010 . 345Figure 8-24: Leading Competitors, Hyaluronic Acid ViscosupplementationMarket, Australia, 2010 . 345ABBREVIATIONS 347APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BYWEIGHT . 348Figure 10-1: Total Synthetic Market, Japan, 2007 – 2017 (US$) 349Figure 10-2: Total Synthetic Market, Japan, 2007 – 2017 (JP¥) . 349Figure 10-3: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$) 350Figure 10-4: Synthetic Total Spine Market, Japan, 2007 – 2017 (JP¥) . 350List of FiguresFigure 10-5: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$) 351Figure 10-6: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (JP¥). 351Figure 10-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017(US$) 352Figure 10-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017(JP¥) . 352Figure 10-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017(US$) 353Figure 10-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017(JP¥) . 353Figure 10-11: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$)354Figure 10-12: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (JP¥) 354APPENDIX 2: TAIWANESE HYALURONIC ACIDVISCOSUPPLEMENTATION MARKET . 355Figure 11-1: Exchange Rate for Currencies, 2010 . 355Figure 11-2: Hyaluronic Acid Viscosupplementation Market, Taiwan,
  13. 13. 2007 – 2017 (US$). 356Figure 11-3: Hyaluronic Acid Viscosupplementation Market, Taiwan,2007 – 2017 (TW$) 356APPENDIX 3: EMERGING MARKETS . 358List of ChartsLIST OF CHART SEXECUTIVE SUMMARY 1RESEARCH METHODOLOGY 8ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET . 19Chart 3-1: Orthopedic Biomaterials Market, Asia-Pacific, 2007 – 2017 (US$M) 23Chart 3-2: Orthopedic Biomaterials Market by Segment, Asia-Pacific,2007 – 2017 (US$M) . 26Chart 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2010 27Chart 3-4: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2017 . 28Chart 3-5: Growth Rates by Segment, Orthopedic Biomaterials Market,Asia-Pacific, 2007 – 2017 31Chart 3-6: Orthopedic Biomaterials Market by Country, Asia-Pacific,2007 – 2017 (US$M) 34Chart 3-7: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2010. 35Chart 3-8: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2017. 36Chart 3-9: Orthopedic Biomaterials Market by Segment, Japan, 2007 – 2017(US$M) . 39Chart 3-10: Orthopedic Biomaterials Market by Segment, Japan, 2010 40Chart 3-11: Orthopedic Biomaterials Market by Segment, Japan, 2017 41Chart 3-12: Orthopedic Biomaterials Market by Segment, China, 2007 – 2017(US$M) . 44Chart 3-13: Orthopedic Biomaterials Market by Segment, China, 2010 45Chart 3-14: Orthopedic Biomaterials Market by Segment, China, 2017 46Chart 3-15: Orthopedic Biomaterials Market by Segment, South Korea,2007 – 2017 (US$M) . 49Chart 3-16: Orthopedic Biomaterials Market by Segment, South Korea, 2010 50Chart 3-17: Orthopedic Biomaterials Market by Segment, South Korea, 2017 51Chart 3-18: Orthopedic Biomaterials Market by Segment, Australia, 2007 – 2017(US$M) 54Chart 3-19: Orthopedic Biomaterials Market by Segment, Australia, 2010. 55List of ChartsChart 3-20: Orthopedic Biomaterials Market by Segment, Australia, 2017. 56Chart 3-21: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific,2010 63Chart 3-22: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010 65COUNTRY PROFILES 67Chart 4-1: Country Profile, Japan, 2010 68Chart 4-2: Country Profile, China, 2010 . 69Chart 4-3: Country Profile, South Korea, 2010 70Chart 4-4: Country Profile, Australia, 2010. 71PROCEDURE NUMBERS 72Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication,Asia-Pacific, 2010 . 74
  14. 14. Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication,Asia-Pacific, 2017 . 75Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment,Asia-Pacific, 2010 . 78Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment,Asia-Pacific, 2017 79Chart 5-5: Total Orthopedic Bone Graft Substitute Procedures by Country,Asia-Pacific, 2010 . 82Chart 5-6: Total Orthopedic Bone Graft Substitute Procedures by Country,Asia-Pacific, 2017 . 83BONE GRAFT SUBSTITUTE MARKET 84Chart 6-1: Total Synthetic Market, Japan, 2007 – 2017 (US$M) 91Chart 6-2: Synthetic Total Spine Market, Japan, 2007 – 2017 (US$M) 94Chart 6-3: Synthetic Cervical Spine Market, Japan, 2007 – 2017 (US$M) 97Chart 6-4: Synthetic Thoracolumbar Spine Market, Japan, 2007 – 2017 (US$M) 100Chart 6-5: Synthetic Trauma & Reconstruction Market, Japan, 2007 – 2017(US$M) . 103Chart 6-6: Synthetic Craniomaxillofacial Market, Japan, 2007 – 2017 (US$M) 106Chart 6-7: Leading Competitors, Bone Graft Substitute Market, Japan, 2010 . 111Chart 6-8: Bone Graft Substitute Market by Segment, China, 2007 – 2017(US$M) . 114Chart 6-9: Bone Graft Substitute Market by Segment, China, 2010 115List of ChartsChart 6-10: Bone Graft Substitute Market by Segment, China, 2017 116Chart 6-11: Total Allograft Market, China, 2007 – 2017 (US$M) 119Chart 6-12: Allograft Total Spine Market, China, 2007 – 2017 (US$M). 122Chart 6-13: Allograft Cervical Spine Market, China, 2007 – 2017 (US$M) 125Chart 6-14: Allograft Thoracolumbar Spine Market, China, 2007 – 2017(US$M) . 128Chart 6-15: Allograft Trauma & Reconstruction Market, China, 2007 – 2017(US$M) . 131Chart 6-16: Allograft Craniomaxillofacial Market, China, 2007 – 2017 (US$M) 134Chart 6-17: Total Synthetic Market, China, 2007 – 2017 (US$M) 137Chart 6-18: Synthetic Total Spine Market, China, 2007 – 2017 (US$M) 140Chart 6-19: Synthetic Cervical Spine Market, China, 2007 – 2017 (US$M) . 143Chart 6-20: Synthetic Thoracolumbar Spine Market, China, 2007 – 2017(US$M) . 146Chart 6-21: Synthetic Trauma & Reconstruction Market, China, 2007 – 2017(US$M) . 149Chart 6-22: Synthetic Craniomaxillofacial Market, China, 2007 – 2017 (US$M) 152Chart 6-23: Total DBM Market, China, 2007 – 2017 (US$M) 155Chart 6-24: DBM Total Spine Market, China, 2007 – 2017 (US$M) 158Chart 6-25: DBM Cervical Spine Market, China, 2007 – 2017 (US$M) . 161Chart 6-26: DBM Thoracolumbar Spine Market, China, 2007 – 2017 (US$M) . 164Chart 6-27: DBM Trauma & Reconstruction Market, China, 2007 – 2017(US$M) . 167Chart 6-28: DBM Craniomaxillofacial Market, China, 2007 – 2017 (US$M) 170Chart 6-29: Leading Competitors, Bone Graft Substitute Market, China, 2010 175Chart 6-30: Bone Graft Substitute Market by Segment, South Korea, 2007 – 2017
  15. 15. (US$M) . 178Chart 6-31: Bone Graft Substitute Market by Segment, South Korea, 2010 179Chart 6-32: Bone Graft Substitute Market by Segment, South Korea, 2017 180Chart 6-33: Total Allograft Market, South Korea, 2007 – 2017 (US$M) 183Chart 6-34: Allograft Total Spine Market, South Korea, 2007 – 2017 (US$M). 186Chart 6-35: Allograft Cervical Spine Market, South Korea, 2007 – 2017(US$M) . 189List of ChartsChart 6-36: Allograft Thoracolumbar Spine Market, South Korea, 2007 – 2017(US$M) . 192Chart 6-37: Allograft Trauma & Reconstruction Market, South Korea,2007 – 2017 (US$M) . 195Chart 6-38: Allograft Craniomaxillofacial Market, South Korea, 2007 – 2017(US$M) . 198Chart 6-39: Total Synthetic Market, South Korea, 2007 – 2017 (US$M) 201Chart 6-40: Synthetic Total Spine Market, South Korea, 2007 – 2017 (US$M) 204Chart 6-41: Synthetic Cervical Spine Market, South Korea, 2007 – 2017(US$M) . 207Chart 6-42: Synthetic Thoracolumbar Spine Market, South Korea, 2007 – 2017(US$M) . 210Chart 6-43: Synthetic Trauma & Reconstruction Market, South Korea,2007 – 2017 (US$M) . 213Chart 6-44: Synthetic Craniomaxillofacial Market, South Korea, 2007 – 2017(US$M) . 216Chart 6-45: Total DBM Market, South Korea, 2007 – 2017 (US$M) 219Chart 6-46: DBM Total Spine Market, South Korea, 2007 – 2017 (US$M) 222Chart 6-47: DBM Cervical Spine Market, South Korea, 2007 – 2017 (US$M) 225Chart 6-48: DBM Thoracolumbar Spine Market, South Korea, 2007 – 2017(US$M) . 228Chart 6-49: DBM Trauma & Reconstruction Market, South Korea, 2007 – 2017(US$M) . 231Chart 6-50: DBM Craniomaxillofacial Market, South Korea, 2007 – 2017(US$M) . 234Chart 6-51: Leading Competitors, Bone Graft Substitute Market, South Korea,2010 240Chart 6-52: Bone Graft Substitute Market by Segment, Australia, 2007 – 2017(US$M) . 243Chart 6-53:Bone Graft Substitute Market by Segment, Australia, 2010 244Chart 6-54: Bone Graft Substitute Market by Segment, Australia, 2017 . 245Chart 6-55: Total Allograft Market, Australia, 2007 – 2017 (US$M) . 249Chart 6-56: Allograft Total Spine Market, Australia, 2007 – 2017 (US$M) 252Chart 6-57: Allograft Cervical Spine Market, Australia, 2007 – 2017 (US$M) . 255List of ChartsChart 6-58: Allograft Thoracolumbar Spine Market, Australia, 2007 – 2017(US$M) . 258Chart 6-59: Allograft Trauma & Reconstruction Market, Australia, 2007 – 2017(US$M) . 261Chart 6-60: Allograft Craniomaxillofacial Market, Australia, 2007 – 2017(US$M) . 264
  16. 16. Chart 6-61: Total Synthetic Market, Australia, 2007 – 2017 (US$M). 267Chart 6-62: Synthetic Total Spine Market, Australia, 2007 – 2017 (US$M) . 270Chart 6-63: Synthetic Cervical Spine Market, Australia, 2007 – 2017 (US$M) 273Chart 6-64: Synthetic Thoracolumbar Spine Market, Australia, 2007 – 2017(US$M) . 276Chart 6-65: Synthetic Trauma & Reconstruction Market, Australia, 2007 – 2017(US$M) . 279Chart 6-66: Synthetic Craniomaxillofacial Market, Australia, 2007 – 2017(US$M) . 282BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPYMARKET 289Chart 7-1: Bone Morphogenetic Market, Australia, 2007 – 2017 (US$M) 293Chart 7-2: Leading Competitors, Bone Morphogenetic Protein Market, Australia,2010 298HYALURONIC ACID VISCOSUPPLEMENTATION MARKET. 299Chart 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 – 2017(US$M) . 303Chart 8-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market,Japan, 2010 . 308Chart 8-3: Total Hyaluronic Acid Viscosupplementation Market, China,2007 – 2017 (US$M) . 311Chart 8-4: Total Hyaluronic Acid Viscosupplementation Market, China, 2010 . 312Chart 8-5: Total Hyaluronic Acid Viscosupplementation Market, China, 2017 . 313Chart 8-6: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market,China, 2007 – 2017 (US$M) 316Chart 8-7: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market,China, 2007 – 2017 (US$M) 319List of ChartsChart 8-8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market,China, 2010 . 324Chart 8-9: Total Hyaluronic Acid Viscosupplementation Market, South Korea,2007 – 2017 (US$M) . 327Chart 8-10: Total Hyaluronic Acid Viscosupplementation Market, South Korea,2010 328Chart 8-11: Total Hyaluronic Acid Viscosupplementation Market, South Korea,2017 329Chart 8-12: Three-Injection Cycle Hyaluronic Acid ViscosupplementationMarket, South Korea, 2007 – 2017 (US$M). 332Chart 8-13: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market,South Korea, 2007 – 2017 (US$M) 335Chart 8-14: Leading Competitors, Hyaluronic Acid ViscosupplementationMarket, South Korea, 2010 . 340Chart 8-15: Hyaluronic Acid Viscosupplementation Market, Australia, 2010 –2017 (US$M). 343Chart 8-16: Leading Competitors, Hyaluronic Acid ViscosupplementationMarket, Australia, 2010 . 346ABBREVIATIONS 347APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BYWEIGHT . 348
  17. 17. APPENDIX 2: TAIWANESE HYALURONIC ACIDVISCOSUPPLEMENTATION MARKET . 355Chart 11-1: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 – 2017(US$M) . 357APPENDIX 3: EMERGING MARKETS . 358About Us:ReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: +1-888-989-8004E-mail: sales@reportsnreports.comhttp://www.reportsnreports.comBlog: http://www.reportsnreportsblog.com

×